Glycol Chitosan-Based Fluorescent Theranostic Nanoagents for Cancer Therapy
- Authors
- Rhee, Jin-Kyu; Park, Ok Kyu; Lee, Aeju; Yang, Dae Hyeok; Park, Kyeongsoon
- Issue Date
- Dec-2014
- Publisher
- MDPI
- Keywords
- glycol chitosan; theranostics; nanosystem; fluorescence; cancer
- Citation
- MARINE DRUGS, v.12, no.12, pp 6038 - 6057
- Pages
- 20
- Journal Title
- MARINE DRUGS
- Volume
- 12
- Number
- 12
- Start Page
- 6038
- End Page
- 6057
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/51429
- DOI
- 10.3390/md12126038
- ISSN
- 1660-3397
- Abstract
- Theranostics is an integrated nanosystem that combines therapeutics with diagnostics in attempt to develop new personalized treatments with enhanced therapeutic efficacy and safety. As a promising therapeutic paradigm with cutting-edge technologies, theranostic agents are able to simultaneously deliver therapeutic drugs and diagnostic imaging agents and also monitor the response to therapy. Polymeric nanosystems have been intensively explored for biomedical applications to diagnose and treat various cancers. In recent years, glycol chitosan-based nanoagents have been developed as dual-purpose materials for simultaneous diagnosis and therapy. They have shown great potential in cancer therapies, such as chemotherapeutics and nucleic acid and photodynamic therapies. In this review, we summarize the recent progress and potential applications of glycol chitosan-based fluorescent theranostic nanoagents for cancer treatments and discuss their possible underlying mechanisms.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Biotechnology & Natural Resource > Department of Systems Biotechnology > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/51429)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.